CpG ODN enhances the efficacy of F protein vaccine against respiratory syncytial virus infection in the upper respiratory tract via CD4<sup>+</sup> T cells.

Kawahara, Eigo; Yamamoto, Shinya; Shibata, Takehiko; Hirai, Toshiro; Yoshioka, Yasuo

CpG ODN enhances the efficacy of F protein vaccine against respiratory syncytial virus infection in the upper respiratory tract via CD4⁺ T cells.

Kawahara, Eigo; Yamamoto, Shinya; Shibata, Takehiko; Hirai, Toshiro; Yoshioka, Yasuo.

Afiliación

Kawahara E; Laboratory of Nano-design for Innovative Drug Development, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan; Vaccine Creation Group, Research Institute for Microbial Diseases, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Yamamoto S; The Research Foundation for Microbial Diseases of Osaka University, 3-1 Yamadaoka, Suita, Osaka, 565-0871, Japan; Institute for Open and Transdisciplinary Research Initiatives, Osaka University, 3-1 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Shibata T; Department of Microbiology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo, Japan.
Hirai T; Laboratory of Nano-design for Innovative Drug Development, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan; Vaccine Creation Group, Research Institute for Microbial Diseases, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan; In
Yoshioka Y; Laboratory of Nano-design for Innovative Drug Development, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan; Vaccine Creation Group, Research Institute for Microbial Diseases, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan; Th

Biochem Biophys Res Commun ; 686: 149143, 2023 12 17.

Article en En | MEDLINE | ID: mdl-37926041

Asunto(s)

Infecciones por Virus Sincitial Respiratorio; Virus Sincitial Respiratorio Humano; Vacunas; Ratones; Humanos; Animales; Anciano; Infecciones por Virus Sincitial Respiratorio/prevención & control; Anticuerpos Antivirales; Anticuerpos Neutralizantes; Células TH1; Nariz; Oligodesoxirribonucleótidos; Ratones Endogámicos BALB C

Palabras clave

CD4(+) T cells; CpG ODN; Fusion glycoprotein; Respiratory syncytial virus; Upper respiratory tract; Vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas / Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio Idioma: En Revista: Biochem Biophys Res Commun Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google